GIC 1002Alternative Names: GIC-1002; Non-H2S releasing tosylate salt - gIcare Pharma
Latest Information Update: 06 Apr 2016
At a glance
- Originator gIcare Pharma
- Class Opioid analgesics
- Mechanism of Action Opioid receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Procedural pain
Most Recent Events
- 01 Dec 2014 gIcare Pharma completes a phase I trial in Healthy volunteers (NCT02276768)
- 01 Oct 2014 Phase-I clinical trials in Procedural pain (In volunteers) in Canada (PO) (NCT02276768)